PMC:7519301 / 8724-9239 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T31","span":{"begin":109,"end":115},"obj":"Body_part"},{"id":"T32","span":{"begin":472,"end":479},"obj":"Body_part"},{"id":"T33","span":{"begin":484,"end":492},"obj":"Body_part"}],"attributes":[{"id":"A31","pred":"fma_id","subj":"T31","obj":"http://purl.org/sig/ont/fma/fma84116"},{"id":"A32","pred":"fma_id","subj":"T32","obj":"http://purl.org/sig/ont/fma/fma84116"},{"id":"A33","pred":"fma_id","subj":"T33","obj":"http://purl.org/sig/ont/fma/fma14542"}],"text":"To characterize SARS-CoV-2 diversification since the beginning of the epidemic, we aligned 27,977 SARS-CoV-2 genome sequences isolated from infected individuals in 84 countries. The alignment was curated to retain independent sequences that covered over 95% of the ORFs. In addition, because sequences from the United Kingdom constituted 47% of the dataset (n = 12,157), we sampled a representative set of 5,000 UK sequences, yielding a final dataset of 18,514 SARS-CoV-2 genomes (SI Appendix, Fig. S1 and Fig. 1A)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T76","span":{"begin":16,"end":24},"obj":"Disease"},{"id":"T77","span":{"begin":16,"end":20},"obj":"Disease"},{"id":"T78","span":{"begin":98,"end":106},"obj":"Disease"},{"id":"T79","span":{"begin":98,"end":102},"obj":"Disease"},{"id":"T80","span":{"begin":461,"end":469},"obj":"Disease"},{"id":"T81","span":{"begin":461,"end":465},"obj":"Disease"}],"attributes":[{"id":"A76","pred":"mondo_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A77","pred":"mondo_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A78","pred":"mondo_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A79","pred":"mondo_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A80","pred":"mondo_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A81","pred":"mondo_id","subj":"T81","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"To characterize SARS-CoV-2 diversification since the beginning of the epidemic, we aligned 27,977 SARS-CoV-2 genome sequences isolated from infected individuals in 84 countries. The alignment was curated to retain independent sequences that covered over 95% of the ORFs. In addition, because sequences from the United Kingdom constituted 47% of the dataset (n = 12,157), we sampled a representative set of 5,000 UK sequences, yielding a final dataset of 18,514 SARS-CoV-2 genomes (SI Appendix, Fig. S1 and Fig. 1A)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T85","span":{"begin":382,"end":383},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T86","span":{"begin":435,"end":436},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T87","span":{"begin":499,"end":501},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"}],"text":"To characterize SARS-CoV-2 diversification since the beginning of the epidemic, we aligned 27,977 SARS-CoV-2 genome sequences isolated from infected individuals in 84 countries. The alignment was curated to retain independent sequences that covered over 95% of the ORFs. In addition, because sequences from the United Kingdom constituted 47% of the dataset (n = 12,157), we sampled a representative set of 5,000 UK sequences, yielding a final dataset of 18,514 SARS-CoV-2 genomes (SI Appendix, Fig. S1 and Fig. 1A)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T27","span":{"begin":481,"end":483},"obj":"Chemical"}],"attributes":[{"id":"A27","pred":"chebi_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/CHEBI_90326"}],"text":"To characterize SARS-CoV-2 diversification since the beginning of the epidemic, we aligned 27,977 SARS-CoV-2 genome sequences isolated from infected individuals in 84 countries. The alignment was curated to retain independent sequences that covered over 95% of the ORFs. In addition, because sequences from the United Kingdom constituted 47% of the dataset (n = 12,157), we sampled a representative set of 5,000 UK sequences, yielding a final dataset of 18,514 SARS-CoV-2 genomes (SI Appendix, Fig. S1 and Fig. 1A)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"184","span":{"begin":16,"end":26},"obj":"Species"},{"id":"185","span":{"begin":98,"end":108},"obj":"Species"},{"id":"186","span":{"begin":461,"end":471},"obj":"Species"},{"id":"187","span":{"begin":140,"end":148},"obj":"Disease"}],"attributes":[{"id":"A184","pred":"tao:has_database_id","subj":"184","obj":"Tax:2697049"},{"id":"A185","pred":"tao:has_database_id","subj":"185","obj":"Tax:2697049"},{"id":"A186","pred":"tao:has_database_id","subj":"186","obj":"Tax:2697049"},{"id":"A187","pred":"tao:has_database_id","subj":"187","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"To characterize SARS-CoV-2 diversification since the beginning of the epidemic, we aligned 27,977 SARS-CoV-2 genome sequences isolated from infected individuals in 84 countries. The alignment was curated to retain independent sequences that covered over 95% of the ORFs. In addition, because sequences from the United Kingdom constituted 47% of the dataset (n = 12,157), we sampled a representative set of 5,000 UK sequences, yielding a final dataset of 18,514 SARS-CoV-2 genomes (SI Appendix, Fig. S1 and Fig. 1A)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T57","span":{"begin":0,"end":177},"obj":"Sentence"},{"id":"T58","span":{"begin":178,"end":270},"obj":"Sentence"},{"id":"T59","span":{"begin":271,"end":515},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"To characterize SARS-CoV-2 diversification since the beginning of the epidemic, we aligned 27,977 SARS-CoV-2 genome sequences isolated from infected individuals in 84 countries. The alignment was curated to retain independent sequences that covered over 95% of the ORFs. In addition, because sequences from the United Kingdom constituted 47% of the dataset (n = 12,157), we sampled a representative set of 5,000 UK sequences, yielding a final dataset of 18,514 SARS-CoV-2 genomes (SI Appendix, Fig. S1 and Fig. 1A)."}